Post by Wyss Institute at Harvard University

The Wyss Institute’s inaugural Application-Driven AI Symposium brought together investors and leaders from pharma, biotech, tech, and academia to explore how AI is reshaping the life sciences. Building on the Wyss’s new AI DataHub and Translational AI Catalyst, this symposium highlighted how tightly integrated data, engineering, and biology are enabling a next generation of AI/Bio innovation and accelerating the path from discovery to real-world impact. Through sessions on “Closing the Loop: Integrating AI with Experimental Science,” “AI Across Functional Boundaries — From Insight to Execution,” and “From Prediction to Patients: AI in Therapeutic Discovery,” participants learned from researchers and innovators who use AI as a tool to design better experiments, de-risk R&D, and translate predictions into therapies and products. They discussed where closed-loop AI can be most useful and where human interaction is needed to fully interrogate biological complexity. Learn more about the Translational AI Catalyst and how you can get involved: https://lnkd.in/eK7k9TA7